
Insurance brokerage firm Brown & Brown (NYSE: BRO) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 30.4% year on year to $1.68 billion. Its non-GAAP profit of $1.07 per share was in line with analysts’ consensus estimates.
Is now the time to buy BRO? Find out in our full research report (it’s free for active Edge members).
Brown & Brown (BRO) Q2 CY2026 Highlights:
- Revenue: $1.68 billion vs analyst estimates of $1.72 billion (30.4% year-on-year growth, 2.5% miss)
- Adjusted EPS: $1.07 vs analyst estimates of $1.07 (in line)
- Adjusted EBITDA: $608.5 million vs analyst estimates of $603.1 million (36.3% margin, 0.9% beat)
- Operating Margin: 22.9%, down from 24.2% in the same quarter last year
- Market Capitalization: $23.32 billion
StockStory’s Take
Brown & Brown’s second quarter results for 2026 fell short of market revenue expectations, but sales still rose 30.4% year on year to $1.68 billion. Management attributed performance to strong contingent commissions, effective integration of acquisitions, and ongoing enhancements to its sales and underwriting processes. CEO J. Powell Brown emphasized, “Our enhanced go-to-market sales model is building momentum with newly aligned teams collaborating, developing opportunities, and generating incremental new business wins.” The company also noted progress in controlling expenses, even as operating margin declined year-over-year, and highlighted solid cash flow generation and share repurchases as additional contributors to the quarter’s outcomes.
Looking forward, Brown & Brown’s guidance is shaped by expectations for continued organic growth, efficiency gains from AI initiatives, and disciplined capital deployment. Management is focused on leveraging new technology partnerships to enhance productivity and accelerate workflow improvements. CFO R. Watts stated, “We anticipate incremental organic growth and margin expansion will occur over the coming quarters and years as AI, data, and analytics become more embedded in our workflows.” The company is also preparing for ongoing competitive pressures in commercial insurance pricing and is targeting further integration synergies from recent acquisitions, while maintaining flexibility to redirect capital between share repurchases, technology investments, and selective M&A.
Key Insights from Management’s Remarks
Management cited robust contingent commission growth, successful integration of Accession, and early returns from enhanced technology and AI partnerships as key drivers of Q2 performance.
- Contingent commissions boost: Management highlighted that increased contingent commissions, particularly from both retail and specialty distribution segments, played a significant role in supporting revenue growth. These are additional payments from insurers tied to profitability or volume thresholds, and this quarter benefited from favorable underwriting results and minimal storm claim activity.
- Accession integration progress: The integration of Accession, a major acquisition, was described as on track, with its revenues and margins aligning with internal expectations. The transaction’s benefits were partially offset by onetime earnout-related cash flow impacts, which management stated would not recur in future periods.
- Organic growth momentum: Retail organic growth, when including contingents, was slightly above expectations, aided by a new sales approach and improved collaboration across teams. However, management acknowledged that specialty distribution organic growth was negatively affected by delayed new business revenue, expected to be recognized in the third quarter.
- AI and technology partnerships: The company announced new partnerships with McKinsey, Accenture, and Anthropic aimed at accelerating use of artificial intelligence across sales, underwriting, and support functions. These initiatives are designed to drive faster cycle times, higher productivity, and, over time, stronger organic growth.
- Expense management and margin dynamics: While operating margins declined year-over-year (operating margin at 22.9%, down from 24.2% last year), management cited disciplined expense control, synergies from recent acquisitions, and one-time accrual adjustments as factors that partially offset margin pressures. They expect some of these benefits to moderate over time as hiring to replace departed employees continues.
Drivers of Future Performance
Management expects future performance to be driven by further integration benefits, AI-enabled efficiency gains, and disciplined capital allocation amid a competitive insurance market.
- AI-driven productivity gains: Brown & Brown is prioritizing the embedding of artificial intelligence and advanced analytics into core workflows, with management stating these investments are intended to improve sales, underwriting, and support processes. They believe the impact will become more significant in years three to five after implementation, contributing to incremental margin expansion.
- Acquisition and integration synergies: The company is targeting $30 million to $40 million in cost synergies this year from recent acquisitions, especially Accession. Continued focus on integrating talent and systems is expected to support organic growth and profitability in both the retail and specialty distribution segments.
- Market and pricing headwinds: Management anticipates ongoing pricing competition, particularly in catastrophe (CAT) property and certain casualty insurance lines. They expect downward pressure on CAT property rates to persist unless major loss events occur, while the admitted insurance market is becoming more competitive. These trends could affect both revenue growth and future contingent commissions.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will be monitoring (1) the pace and impact of AI adoption across sales and underwriting workflows, (2) realization of cost synergies and integration benefits from the Accession acquisition, and (3) trends in contingent commissions and organic growth as insurance market competition intensifies. The effectiveness of capital allocation between share repurchases, technology investment, and future M&A will also be important for long-term performance.
Brown & Brown currently trades at $73.17, up from $67.76 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).
Stocks That Trumped Tariffs
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.